Exploring how structural racism affects lung cancer risk in different racial and ethnic groups
Understanding the role of structural racism on racial/ethnic inequities in lung cancer risk
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10872138
This study is looking at how unfair treatment based on race affects the chances of getting lung cancer in African Americans and Native Hawaiians, and it aims to understand the different factors that play a role in this, so we can better support those communities.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10872138 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of structural racism on lung cancer risk among African Americans and Native Hawaiians, who experience higher rates of lung cancer compared to other groups. By utilizing data from large cohorts, the study aims to understand how social determinants of health contribute to these disparities, beyond just genetic and lifestyle factors. The research will analyze various biological markers and environmental influences to provide a comprehensive view of the issue. Participants will be followed over time to gather extensive data on their health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include African American and Native Hawaiian individuals aged 21 and older who are at risk for lung cancer.
Not a fit: Patients from racial/ethnic groups other than African American or Native Hawaiian may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that reduce lung cancer risk and improve health equity for affected populations.
How similar studies have performed: Previous research has shown that addressing social determinants of health can lead to improved health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHENG, IONA C — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: CHENG, IONA C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.